Decotiis Explains Overcoming barriers Oral delivery of GLP-1 therapies is advancing through two complementary strategies that aim to overcome low gastric stability and poor epithelial uptake
Metformin's primary mechanism involves activation of AMP-activated protein kinase (AMPK) in hepatocytes, which suppresses gluconeogenesis and significantly reduces hepatic glucose output
Pernicious anemia is a type of megaloblastic anemia characterized by the production of abnormally large, immature red blood cells due to inadequate vitamin B12 levels
Beyond Supplements: Lifestyle Support While supplementation forms the foundation of this approach, supporting your body's natural production of both compounds amplifies the benefits
However, compounded medications are not FDA-approved finished products
As depicted in Figure 3D, AICAR treatment significantly inhibited the phosphorylation of PARP-1 while it increased the ABCA1 protein level